awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38170576-601C1D94-51E1-40A4-BA35-3FB7082F8D9C
Q38170576-601C1D94-51E1-40A4-BA35-3FB7082F8D9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38170576-601C1D94-51E1-40A4-BA35-3FB7082F8D9C
Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature.
P2860
Q38170576-601C1D94-51E1-40A4-BA35-3FB7082F8D9C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38170576-601C1D94-51E1-40A4-BA35-3FB7082F8D9C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
45d793bb7449a83525365887b1f3b76b05af8d7f
P2860
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (